If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
137.00    0.00 (0.00%)
Bid:
136.40
Ask:
137.20
Spread: 0.80 (0.587%)
Market Cap: £280.98m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Director / PCA Shareholdings

15 Jun 2026 14:39

RNS Number : 3581I
Forterra plc
15 June 2026
 

15 June 2026

Forterra plc (the "Company")

Director / PCA Shareholdings

The Company was notified on 12 June 2026 that the following share transactions took place (the "Transactions"):

On the 12th of June 2025 Neil Ash, Chief Executive Officer purchased 17,500 ordinary shares of 1p each ("Ordinary Shares") in the Company at a price of £1.324.

On the 12th of June 2026 Neil Ash's spouse, Edyta Ash purchased 11,500 ordinary shares of 1p each ("Ordinary Shares") in the Company at a price of £1.331.

Also, on the 12th of June 2026 Nigel Lingwood, Chair purchased 25,000 ordinary shares of 1p each ("Ordinary Shares") in the Company at a price of £1.328.

Neil Ash's total beneficial interest in the Ordinary Shares of the Company, including those held by his spouse, is 172,554.

Nigel Lingwood's total beneficial interest in the Ordinary Shares of the Company, is 75,000.

 

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations.

 

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Frances Tock (Company Secretary)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Vicky Hayns

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Neil Ash

2.

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

213800O5DD6ATBVJAD23

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

Purchased

£1.315

6,502

d)

Price(s) and volume(s)

Transaction

Price(s)

 Volume(s)

Purchased

£1.316

 10,600

e)

Price(s) and volume(s)

Transaction

Price(s)

 Volume(s)

Purchased

£1.338

 398

f)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

Purchased

£1.324

17,500

£23,170

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Edyta Ash

2.

Reason for the notification

a)

Position/status

PCA of PDMR 

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

213800O5DD6ATBVJAD23

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

Purchased

£1.323

2,646

d)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

Purchased

£1.321

8,475

e)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

Purchased

£1.332

379

f)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

Purchased

£1.331

11,500

£15,307

 

 

 

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Nigel Lingwood

2.

Reason for the notification

a)

Position/status

PDMR (Chair)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

213800O5DD6ATBVJAD23

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

Purchased

£1.328

25,000

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 Sold

£1.328

25,000

£33,200

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFAMJTMTJBBFF
Date   Source Headline
2nd Nov 20215:12 pmRNSEmployee Benefit Trust Share Purchase
1st Nov 20211:51 pmRNSDirector Declaration
13th Oct 20217:06 amRNSHolding(s) in Company
7th Oct 20215:12 pmRNSDirector/PDMR Shareholding
6th Oct 20217:51 amRNSHolding(s) in Company
5th Oct 20215:49 pmRNSEmployee Benefit Trust Share Purchase
28th Sep 20219:28 amRNSEmployee Benefit Trust Share Purchase
23rd Sep 20218:33 amRNSHolding(s) in Company
21st Sep 20218:11 amRNSHolding(s) in Company
17th Sep 202111:21 amRNSDirector Declaration
3rd Sep 20213:22 pmRNSEmployee Benefit Trust Share Purchase
27th Aug 20212:58 pmRNSDirector/PDMR Shareholding
27th Aug 202111:15 amRNSDirector Declaration
26th Aug 20217:00 amRNSDisposal of Swadlincote site
9th Aug 20219:32 amRNSHolding(s) in Company
3rd Aug 20212:49 pmRNSEmployee Benefit Trust Share Purchase
29th Jul 20217:56 amRNSProgressive publishes new research
29th Jul 20217:00 amRNSHalf-year Report
13th Jul 20216:03 pmRNSDirector/PDMR Shareholding
5th Jul 202111:22 amRNSEmployee Benefit Trust Share Purchase
15th Jun 20219:56 amRNSDirector/PDMR Shareholding
7th Jun 20219:24 amRNSEmployee Benefit Trust Share Purchase
27th May 20213:45 pmRNSDirector/PDMR Shareholding
18th May 20213:45 pmRNSAnnual General Meeting 2021 Results
18th May 202110:28 amRNSProgressive publishes new research
18th May 20217:00 amRNSTrading Statement
6th May 20217:00 amRNSEmployee Benefit Trust Share Purchase
30th Apr 20214:07 pmRNSHolding(s) in Company
30th Apr 20211:11 pmRNSGrant under Performance Share Plan
9th Apr 20213:46 pmRNSDirector/PDMR Shareholding
9th Apr 202110:56 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSAnnual Report 2020 and Notice of AGM 2021
8th Apr 20213:31 pmRNSEmployee Benefit Trust Share Purchase
1st Apr 202110:59 amRNSDirector/PDMR Shareholding
30th Mar 20211:14 pmRNSDirector/PDMR Shareholding
25th Mar 20212:41 pmRNSDirector/PDMR Shareholding
22nd Mar 20213:55 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNS2020 FULL YEAR RESULTS
4th Mar 20217:24 amRNSHolding(s) in Company
3rd Mar 202110:36 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSEmployee Benefit Trust Share Purchase
17th Feb 20213:16 pmRNSHolding(s) in Company
15th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20212:16 pmRNSDirector/PDMR Shareholding
2nd Feb 20214:17 pmRNSEmployee Benefit Trust Share Purchase
1st Feb 20214:48 pmRNSDirector/PDMR Shareholding
28th Jan 202112:38 pmRNSHolding(s) in Company
27th Jan 20213:40 pmRNSHolding(s) in Company
26th Jan 20218:15 amRNSProgressive publishes new research

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.